Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
25-Mar-2025 | 1,210.3 | 1,215.95 | 1,167.95 | 1,177.9 | 98,645 | 3,37,09,01,737.45 | 15,36,638 |
26-Mar-2025 | 1,177.9 | 1,179.8 | 1,152.65 | 1,164.6 | 1,34,793 | 3,33,38,49,572.85 | 16,24,386 |
27-Mar-2025 | 1,160 | 1,172.4 | 1,144 | 1,162.2 | 1,41,276 | 5,14,74,81,095.4 | 31,11,148 |
28-Mar-2025 | 1,159.25 | 1,159.25 | 1,140.75 | 1,144.2 | 95,730 | 3,17,18,38,628.35 | 18,14,211 |
01-Apr-2025 | 1,144.2 | 1,164.4 | 1,136.05 | 1,152.2 | 98,563 | 4,79,47,16,300.25 | 28,88,867 |
02-Apr-2025 | 1,150 | 1,152.7 | 1,135 | 1,150 | 60,874 | 2,36,85,26,047.9 | 14,08,219 |
03-Apr-2025 | 1,190.5 | 1,226.9 | 1,149.05 | 1,151.45 | 1,75,194 | 7,47,14,13,120.45 | 25,70,321 |
04-Apr-2025 | 1,151.8 | 1,157.45 | 1,076.2 | 1,109.95 | 2,06,413 | 5,98,67,09,250.8 | 29,12,097 |
07-Apr-2025 | 1,020 | 1,098.85 | 1,020 | 1,087.9 | 1,36,195 | 4,22,58,40,425.7 | 21,79,032 |
08-Apr-2025 | 1,100 | 1,113.65 | 1,088.7 | 1,107.95 | 79,851 | 1,74,03,91,167.9 | 8,12,494 |
09-Apr-2025 | 1,094.5 | 1,103.25 | 1,061.65 | 1,094.05 | 1,17,243 | 6,01,49,46,285.75 | 38,90,569 |
11-Apr-2025 | 1,139.9 | 1,139.9 | 1,102.25 | 1,109.5 | 91,866 | 3,06,89,04,560.9 | 17,18,578 |
15-Apr-2025 | 1,140.9 | 1,158.1 | 1,129 | 1,154.9 | 72,640 | 3,07,68,69,271.1 | 16,90,775 |
16-Apr-2025 | 1,150.2 | 1,161.4 | 1,143.7 | 1,158.4 | 77,501 | 1,67,50,01,335.4 | 8,65,945 |
17-Apr-2025 | 1,150.1 | 1,173.6 | 1,150.1 | 1,163.6 | 72,694 | 3,24,75,79,205.9 | 18,10,430 |
21-Apr-2025 | 1,163.4 | 1,179.7 | 1,155 | 1,177.4 | 66,564 | 2,26,80,03,614.4 | 12,77,733 |
22-Apr-2025 | 1,173.9 | 1,180.5 | 1,162.3 | 1,175 | 42,491 | 1,54,17,16,008 | 6,74,285 |
23-Apr-2025 | 1,185.1 | 1,191.8 | 1,175.9 | 1,186 | 82,010 | 3,77,92,09,145.2 | 22,05,655 |
Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.
Here are some of the stocks that may see significant price movement today: KPI Green, Tata Power, UltraTech Cement, etc.
Dr Reddy's Laboratories third quarter net profit rose 2.5% year-on-year (YoY) to ₹1,413.3 crore.
The company logged a growth of 15.9% in its revenue from operations at ₹8,358.60 Crore versus ₹7,215 Crore in Q3FY24.
Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.
Here are some of the stocks that may see significant price movement today: Dr Reddy’s Laboratories, RITES, Canara Bank, etc.
Dr Reddy's already signed a license and commercialisation deal for Toripalimab with Shanghai Junshi Biosciences Co. Ltd in 2023.
Dr Reddy’s Laboratories shares has gained a total of 5.62% in the last one year, and 2.45% since the beginning of the year.
Here are some of the stocks that may see significant price movement today: UPL, Tata Power, JSW Steel, Dr Reddy’s, etc.
EBITDA for the quarter increased 5% year-on-year to ₹2,280 Crore between July and September 2024, while margins improved modestly to 28.4%.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
